Research progress in drugs for chronic obstructive pulmonary disease therapy
10.3969/j.issn.1006-0111.2017.03.003
- VernacularTitle:慢性阻塞性肺疾病治疗药物研究进展
- Author:
Zhicheng LUO
1
;
Guozhen WU
;
Xing YUAN
Author Information
1. 江西中医药大学药学院
- Keywords:
COPD;
drugs for therapy;
bronchiectasis;
anti-inflammatory;
anti-oxidant
- From:
Journal of Pharmaceutical Practice
2017;35(3):201-204,242
- CountryChina
- Language:Chinese
-
Abstract:
Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease characterized by incompletely reversible airflow limitation and progressive course.The pathogenesis of COPD is complicated.Clinical symptoms include declining pulmonary function, airway and lung inflammation, cough, emaciation, low activity and so on.In the past, the medications for COPD treatment were mainly bronchodilators and anti-inflammatory drugs.With the better understanding of its pathogenesis, anti-oxidative drugs have also been used in the clinical treatment of COPD recently.This article reviews the development of drugs which include bronchodilators, anti-inflammatory drugs and anti-oxidative drugs for the therapy of COPD.
